Capital Fund Management S.A. boosted its position in shares of Cabot Corporation (NYSE:CBT - Free Report) by 185.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 63,269 shares of the specialty chemicals company's stock after buying an additional 41,123 shares during the period. Capital Fund Management S.A. owned 0.12% of Cabot worth $5,260,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of CBT. LSV Asset Management increased its stake in Cabot by 318.0% during the 1st quarter. LSV Asset Management now owns 571,034 shares of the specialty chemicals company's stock worth $47,476,000 after buying an additional 434,434 shares in the last quarter. American Century Companies Inc. grew its position in shares of Cabot by 13.2% in the first quarter. American Century Companies Inc. now owns 1,498,268 shares of the specialty chemicals company's stock valued at $124,566,000 after purchasing an additional 174,921 shares in the last quarter. Nuveen LLC purchased a new stake in shares of Cabot in the first quarter valued at approximately $12,365,000. Millennium Management LLC grew its position in shares of Cabot by 67.7% in the fourth quarter. Millennium Management LLC now owns 349,369 shares of the specialty chemicals company's stock valued at $31,901,000 after purchasing an additional 141,050 shares in the last quarter. Finally, GAMMA Investing LLC grew its position in shares of Cabot by 10,385.0% in the first quarter. GAMMA Investing LLC now owns 141,338 shares of the specialty chemicals company's stock valued at $11,751,000 after purchasing an additional 139,990 shares in the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on CBT. Wall Street Zen lowered Cabot from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. UBS Group set a $82.00 price objective on Cabot and gave the stock a "neutral" rating in a research report on Tuesday, August 5th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $92.33.
Get Our Latest Analysis on Cabot
Cabot Trading Up 0.5%
NYSE:CBT traded up $0.44 during trading hours on Wednesday, reaching $82.00. 163,386 shares of the stock were exchanged, compared to its average volume of 422,944. The company has a quick ratio of 1.41, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. The business has a 50-day moving average of $77.01 and a two-hundred day moving average of $78.80. Cabot Corporation has a twelve month low of $70.40 and a twelve month high of $117.46. The company has a market capitalization of $4.36 billion, a price-to-earnings ratio of 10.71 and a beta of 0.87.
Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.80 by $0.10. The business had revenue of $923.00 million for the quarter, compared to analysts' expectations of $957.29 million. Cabot had a return on equity of 25.68% and a net margin of 11.14%. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. On average, equities analysts predict that Cabot Corporation will post 7.57 EPS for the current year.
Cabot Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 11th. Stockholders of record on Friday, August 29th will be paid a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.2%. Cabot's payout ratio is currently 23.53%.
Insider Activity
In other news, CEO Sean D. Keohane sold 114,436 shares of the stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $79.28, for a total value of $9,072,486.08. Following the sale, the chief executive officer directly owned 361,518 shares in the company, valued at approximately $28,661,147.04. This trade represents a 24.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 3.03% of the company's stock.
Cabot Company Profile
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Recommended Stories

Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.